Compare Vaxcyte Inc. Common Stock (PCVX) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Tripadvisor Inc Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.16 (market cap $10.63B), while Tripadvisor Inc Common Stock trades at $9.35 (market cap $1.05B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 10.1× Tripadvisor Inc Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Tripadvisor Inc Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Tripadvisor Inc Common Stock for 58 Days on average.
| PCVX | TRIP | |
|---|---|---|
Market Cap | $10.63B | $1.05B |
Volume | 1,525,205 | 2,724,828 |
Sector | Health | Consumer Cyclical |
52-Week High | $73.82 | $16.72 |
52-Week Low | $40.32 | $8.04 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $9.26B | $1.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TripAdvisor (TRIP) trades at $8.74, up 0.23% with neutral technical signals. The stock faces fundamental challenges with a high P/E of 223.25 despite recent earnings misses, though revenue remains stable near $1.9B. Analyst consensus is mixed with a $13.58 price target, while institutional activity shows both new investments and significant selling. Recent news highlights competitive pressures from AI travel tools and a 52-week low hit in September 2026.
The outlook remains cautious with persistent earnings underperformance and search-related headwinds offsetting Viator's strengths. Key risks include AI disruption and uneven travel demand, but the 55% upside to consensus target offers potential if execution improves. Investors should weigh high valuation against modest profitability and competitive threats.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →
